Progenics Pharmaceuticals Inc

CIK 835887 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Progenics Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 8, 2022SC 13G/A0000908834-22-000053
Feb 16, 2021SC 13G/A0001214659-21-001720
Jul 2, 202015-12G0001193125-20-185879
Jun 26, 2020EFFECT9999999995-20-001661
Jun 23, 202040001437749-20-013680
Jun 23, 202040001437749-20-013677
Jun 23, 202040001437749-20-013676
Jun 23, 202040001437749-20-013679
Jun 23, 202040001437749-20-013675
Jun 23, 202040001437749-20-013672
Jun 23, 2020SC 13D/A0001193125-20-176191
Jun 23, 202040001437749-20-013674
Jun 23, 202040001437749-20-013673
Jun 23, 202040001437749-20-013681
Jun 23, 202040001437749-20-013671
Jun 23, 202040001437749-20-013678
Jun 22, 2020S-8 POS0001193125-20-174811
Jun 22, 2020S-8 POS0001193125-20-174807
Jun 22, 2020S-8 POS0001193125-20-174802
Jun 22, 2020S-8 POS0001193125-20-174799
Jun 22, 202025-NSE0001354457-20-000263
Jun 22, 2020S-8 POS0001193125-20-174816
Jun 22, 2020POS AM0001193125-20-174794
Jun 22, 20208-K0001193125-20-174778
Jun 22, 2020S-8 POS0001193125-20-174814